FMFrancesca Romana Monzo

Francesca Romana Monzo

*This is an algorithmically generated author record based on publicly available information.

Francesca Romana Monzo has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Role of Next-Generation Sequencing in Excluding the Nosocomial Origin of a Case of Legionnaires’ Disease Integrating Environmental Surveillance and Clinical Diagnosis

    by Francesco Paglione, Cataldo Maria Mannavola, Marilena La Sorda, Maria Luisa Ricci, Maria Scaturro, Silvia Laura Bosello, Roberta Masnata, Francesca Romana Monzo, Sara Vincenti, Patrizia Laurenti, et al.

    Legionella pneumophila (Lp) remains one of the major causes of community- and hospital-acquired pneumonia, yet its diagnosis and source attribution continue to pose significant challenges. Here, we describe the case of an immunocompromised patient who developed Legionnaires’ disease during hospitalization. Following activation of the hospital’s internal surveillance system, Lp and Legionella anisa (L. anisa) were recovered from multiple water distribution points using a simplified culture-based protocol. Whole-genome sequencing (WGS) demonstrated that all environmental isolates belonged to a single clonal strain, whereas the clinical isolate was genetically unrelated, thereby excluding the hospital water system as the source of infection. Although not implicated in the patient’s disease, the detection of both Lp and L. anisa within the plumbing system highlighted underlying structural contamination and the potential masking effect of non-L. pneumophila species during culture-based surveillance. These findings support the integration of conventional microbiological methods with high-resolution genomic tools to enhance surveillance accuracy, support outbreak investigations, and strengthen public health responses. Overall, this case underscores the value of WGS as a decisive tool for source attribution, including the robust exclusion of a suspected nosocomial source, in complex clinical and environmental scenarios.


  • Open Access

    Detection of ARGs from Gram-Negative Bacteria in Positive Blood Cultures Using a Microarray-Based System: Towards a Molecular Antibiotic Susceptibility Assay

    by Cataldo Maria Mannavola, Giordana Cafaro, Barbara Fiori, Roberto Rosato, Francesca Romana Monzo, Tiziana D’inzeo, Brunella Posteraro, Maurizio Sanguinetti, Flavio De Maio

    Background/Objectives: Antimicrobial resistance (AMR) represents a major global health challenge, driving the need for rapid and accurate diagnostic tools. Novel molecular assays, including multiplex PCR and DNA microarray-based systems, have emerged to detect antimicrobial resistance genes (ARGs) alongside bacterial identification. Methods: In this study, we evaluated the performance of the HybriSpot12 PCR AUTO (HS12a) system and the MDR Direct Flow Chip (MDR-FC) Kit—an automatic microarray assay based on reverse hybridization—for the detection of ARGs directly from positive blood culture (PBC) samples. A total of 111 Gram-negative bacterial isolates (92 Enterobacterales, 14 Acinetobacter baumannii, and 6 Pseudomonas spp.), previously characterized by whole-genome sequencing (WGS), were each used to generate a PBC, which was then analyzed with the HS12a/MDR-FC assay. Results: We demonstrated perfect agreement for the detection of macrolide resistance genes across all bacterial species and high agreement for genes conferring resistance to sulfonamides and β-lactams. In contrast, aminoglycoside resistance genes showed only moderate agreement, with minor discrepancies observed in Klebsiella pneumoniae and Escherichia coli, largely attributable to specific SNP variations. Conclusions: The HS12a/MDR-FC assay includes 51 ARGs, though not all were represented in our isolate set, and some false negatives were observed. Despite these limitations, its broad coverage and rapid turnaround remain advantageous compared to other rapid assays with fewer targets. Future refinements should aim at broader gene coverage, inclusion of key mutations, and detection of emerging variants, making this approach a promising tool for rapid AMR surveillance and antimicrobial stewardship.